113 related articles for article (PubMed ID: 7549213)
1. Clearance of gadolinium chelates by hemodialysis: an in vitro study.
Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA
J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213
[TBL] [Abstract][Full Text] [Related]
2. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
Puttagunta NR; Gibby WA; Puttagunta VL
Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme.
Corot C; Idee JM; Hentsch AM; Santus R; Mallet C; Goulas V; Bonnemain B; Meyer D
J Magn Reson Imaging; 1998; 8(3):695-702. PubMed ID: 9626889
[TBL] [Abstract][Full Text] [Related]
4. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
Puttagunta NR; Gibby WA; Smith GT
Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
[TBL] [Abstract][Full Text] [Related]
5. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.
Gibby WA; Gibby KA; Gibby WA
Invest Radiol; 2004 Mar; 39(3):138-42. PubMed ID: 15076005
[TBL] [Abstract][Full Text] [Related]
8. [Clearance of gadolinium contrast agent by hemodialysis: in vitro and clinical studies].
Katagiri K; Okada S; Kumazaki T; Tsuboi N
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Nov; 58(13):739-44. PubMed ID: 9866990
[TBL] [Abstract][Full Text] [Related]
9. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B
Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065
[TBL] [Abstract][Full Text] [Related]
11. Elimination of gadolinium-DTPA by peritoneal dialysis.
Dörsam J; Knopp MV; Schad L; Piesche S; Carl S; Oesingmann N
Nephrol Dial Transplant; 1995; 10(7):1228-30. PubMed ID: 7478129
[TBL] [Abstract][Full Text] [Related]
12. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
13. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
Runge VM
J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
[TBL] [Abstract][Full Text] [Related]
16. Measurement of Gd-DTPA dialysis clearance rates by using a look-locker imaging technique.
Niendorf ER; Santyr GE; Brazy PC; Grist TM
Magn Reson Med; 1996 Oct; 36(4):571-8. PubMed ID: 8892210
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Nilsson S
Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
[TBL] [Abstract][Full Text] [Related]
18. Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
Vander Elst L; Van Haverbeke Y; Goudemant JF; Muller RN
Magn Reson Med; 1994 Apr; 31(4):437-44. PubMed ID: 8208120
[TBL] [Abstract][Full Text] [Related]
19. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study.
Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T
Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771
[TBL] [Abstract][Full Text] [Related]
20. Elimination of Gd-DTPA by means of hemodialysis.
Haustein J; Schuhmann-Giampieri G
Eur J Radiol; 1990; 11(3):227-9. PubMed ID: 2265637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
